KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutrien (NTR) Cash & Equivalents (2017 - 2025)

Nutrien (NTR) has 9 years of Cash & Equivalents data on record, last reported at $701.0 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 17.82% year-over-year to $701.0 million; the TTM value through Dec 2025 reached $701.0 million, down 17.82%, while the annual FY2025 figure was $701.0 million, 17.82% down from the prior year.
  • Cash & Equivalents reached $701.0 million in Q4 2025 per NTR's latest filing, down from $853.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $941.0 million in Q4 2023 and bottomed at $499.0 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $779.0 million, with a median of $853.0 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: crashed 65.68% in 2021, then skyrocketed 80.56% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $499.0 million in 2021, then surged by 80.56% to $901.0 million in 2022, then grew by 4.44% to $941.0 million in 2023, then dropped by 9.35% to $853.0 million in 2024, then decreased by 17.82% to $701.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $701.0 million in Q4 2025, $853.0 million in Q4 2024, and $941.0 million in Q4 2023.